Frontlight ResearchEarly access
Trial site
L2 Ip Instituto de Pesquisas Clinicas Ltda ME
- 9running trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Multiple sclerosis3 trials
- Alzheimer disease2 trials
- CIDP (chronic inflammatory demyelinating polyneuropathy)1 trial
- Crohn's disease1 trial
- Friedreich ataxia1 trial
- Mild cognitive impairment1 trial
- Parkinson disease1 trial
- Schizophrenia1 trial
- Phase
- Phase 39 trials
- Status
- Active, not recruiting5 trials
- Recruiting4 trials
- Lead sponsor
- Hoffmann-La Roche6 trials
- argenx1 trial
- Biogen1 trial
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company1 trial
Running trials
Recruiting
Active, not recruiting
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
Recruiting
A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
Active, not recruiting
Recruiting
Recruiting
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease1 recruiting
- CIDP (chronic inflammatory demyelinating polyneuropathy)1 recruiting
- Crohn's disease1 recruiting
- Parkinson disease1 recruiting
- Schizophrenia1 recruiting
Site data: ClinicalTrials.govUpdated 17 Nov 2026